.
"Most people wouldn't realise that what the MRI produces in images is not necessarily an exact representation of what is actually going on in a patient," Dr. Diwan says. "Now for the first time we've been able to demonstrate that MRI technology still has considerable room for improvement—and we've shown how it can be done."
Comparing the new technique with what is currently used by radiologists in clinical practices, Dr. Diwan says the difference represents a shift in the way the data is analysed.
"Current techniques see how quickly or slowly individual atoms line up with a magnetic field after a strong burst of radio waves—this is called signal decay," he says.
"Instead of trying to figure out how fast or slow this signal decay is, our technique measures whether the atoms in a sample are lining up at the same speed as each other, or a range of different speeds—hence decay variance."
Dr. Sheldrick says that that disc degeneration is a really complex process, with a combination of lots of changes happening at a microscopic level, not just one simple change.
"Some of the changes, like dehydration, make the individual protons line up faster while other changes, like loss of some long chains of sugars, should make them line up slower, so a really simple measure like the speed with which they line up on average won't capture the process very well because a lot of the changes cancel each other out," he says.
The technique does not require any new or advanced MRI machinery, Dr. Sheldrick adds, and can be used on "virtually all current scanners".
"In fact, we're starting a trial later this year using a current Medicare licensed scanner in Sydney that will be scanning clinical patients during the day and doing our trial at night."
The trial he alludes to will see the application of the decay variance MRI technique to human patients for the first time, as part of a study funded by Swiss not-for-profit, AO Foundation. Dr. Sheldrick says it is important that the MRI technology is advanced for diagnoses in back pain for humans, because "at the moment our ability to tell where back pain is coming from is rubbish".
"This holds back research, and our progress in treating back pain has been minimal, with 95% of people with back pain having no known cause," he says.
"Trying to find treatments for chest pain wouldn't make any progress either if heart attacks, pleurisy, pericarditis, pneumonia, rib fractures, lung cancer and pneumothorax were all grouped together as 'non-specific chest pain'. I don't believe we will make serious progress with finding new treatments for back pain until we know what's causing it in each person."
Dr. Sheldrick says the inability of doctors to determine the cause of back pain leads to a "one size fits all approach to medicine, in which 95% of people get the same treatment".
"Even without finding new treatments, being able to classify people based on the cause of their back pain opens up new avenues for personalised medicine," he says.
"Some people might be better candidates for one exercise regimen, others might be best served by a different exercise regime, while a third group might be best served by surgery."
Dr. Sheldrick says that using the more accurate decay variance technique to diagnose back pain using MRI is probably about three years away from being available to doctors and the general public for clinical use.